Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments CentreNews

SHTAC to assess effectiveness of COVID-19 diagnostic tests and treatments to inform NICE guidance to the NHS

Published: 8 April 2020
Wash your hands
Regular hand washing has been recommended to limit the spread of coronavirus

NICE responds to the challenges of the coronavirus pandemic.

The National Institute for Health and Care Excellence (NICE) has announced that it will prioritise appraisal of the effectiveness and safety of diagnostic tests and treatments for COVID-19, to provide timely guidance on their use within the NHS. Since the beginning of the pandemic many clinical trials and other research studies have begun to test whether existing therapies, originally intended to treat other diseases, can be effective and safe for use against COVID-19. As one of the nine health technology assessment groups providing health technology assessments to inform NICE’s guidance, SHTAC will critically appraise evidence from trials and other studies as soon as it is available. NICE will announce further details of this process in due course.

NICE will also prioritise the appraisal of ‘therapeutically critical’ topics, including all new cancer treatments. Appraisal of all other health technologies which, at the current time, not are considered a priority will be paused and resumed as soon as possible as part of a post-COVID-19 recovery plan. We have updated our Research in progress page to show which of our current health technology assessments for NICE are priority topics, and which are to be paused.

Please visit our website again soon for updates on our work to inform NICE’s COVID-19 technology appraisals, and other COVID-19 evidence initiatives. You can also receive regular updates via our Twitter page, and our email newsletter.

 

Privacy Settings